Importantly, an inhibitory peptide blocking p113-ZRF1 interaction was efficient in suppressing lipid metabolic reprogramming, mitochondrial activity, tumorigenesis, and aggressiveness of NB cells. This evidence concerns the gene DNAJC2 and neuroblastoma.